Using nanotechnology to improve kidney disease treatments
Biomedical Resource Core
['FUNDING_OTHER'] · NORTHWESTERN UNIVERSITY AT CHICAGO · NIH-10914912
This study is exploring new tiny technologies to help doctors better understand and treat kidney diseases, so patients can look forward to improved treatment options in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY AT CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10914912 on ClinicalTrials.gov |
What this research studies
This research focuses on leveraging innovations in nanotechnology to enhance the understanding and treatment of kidney diseases. By utilizing advanced tools and platforms, the project aims to overcome traditional limitations in kidney research, allowing for better analysis of tissue function and cellular characteristics. The initiative is based at Northwestern University, where experts in nanomedicine will provide resources and support to kidney researchers, facilitating the development of more effective therapies. Patients may benefit from improved treatment options as a result of this collaborative effort.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from various kidney diseases who may benefit from innovative treatment approaches.
Not a fit: Patients with non-kidney related conditions or those who do not have access to the resources provided by this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for kidney diseases, improving patient outcomes.
How similar studies have performed: Other research has shown success in using nanotechnology for medical advancements, particularly in areas like oncology and vaccine development, indicating a promising potential for similar approaches in kidney disease.
Where this research is happening
CHICAGO, UNITED STATES
- NORTHWESTERN UNIVERSITY AT CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SCOTT, EVAN ALEXANDER — NORTHWESTERN UNIVERSITY AT CHICAGO
- Study coordinator: SCOTT, EVAN ALEXANDER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.